Trials / Recruiting
RecruitingNCT05787197
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Circulating Tumor DNA in Patients With Colorectal Cancer Undergoing Curative-intent Surgery for Liver Metastases: Prospective, Multicenter, GERCOR Cohort
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 232 (estimated)
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective multicenter cohort study, was designed to explore the prognostic value of ctDNA as a biomarker of disease response and recurrence or death in patients undergoing curative-intent surgical resection of Colorectal cancer liver metastasis.
Detailed description
Blood collection times according to specific clinical situations: * Standard approach * Combined surgery * Reverse strategy * Two-stage hepatectomy
Conditions
Timeline
- Start date
- 2024-01-09
- Primary completion
- 2025-09-25
- Completion
- 2027-06-30
- First posted
- 2023-03-28
- Last updated
- 2025-07-23
Locations
16 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05787197. Inclusion in this directory is not an endorsement.